Erratum to: Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations by Gruzman et al., Rev Diabet Stud 2009, 6(1):13-36

Documenti analoghi

• Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations
  di: Gruzman, Arie, et al.
  Pubblicazione: (2009)
• Small molecule adenosine 5′-monophosphate activated protein kinase (AMPK) modulators and human diseases
  di: Rana, Sandeep, et al.
  Pubblicazione: (2014)
• Adenosine monophosphate-activated protein kinase (AMPK) activators for the prevention, treatment and potential reversal of pathological pain
  di: Price, Theodore J., et al.
  Pubblicazione: (2016)
• Effects of dietary energy level on appetite and central adenosine monophosphate-activated protein kinase (AMPK) in broilers
  di: Hu, Xiyi, et al.
  Pubblicazione: (2019)
• Activation of PPARδ: from computer modelling to biological effects
  di: Kahremany, Shirin, et al.
  Pubblicazione: (2015)